Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (111-120 of 252) with videos related to

Pageof 26
Sort By:
Journal of Cancer Research and Clinical Oncology|March 14, 2021
Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinomaMathilde Barrau, Khawla Maoui, Bertrand Le Roy, et al.
Expert Review of Gastroenterology & Hepatology|October 9, 2024
Therapeutic drug monitoring in inflammatory bowel disease: recent developmentsXavier Roblin, Robert D Little, Nicolas Mathieu, et al.
Viruses|April 26, 2025
Predictive Factors of Cytomegalovirus Colonic Reactivation in Patients with Active Ulcerative ColitisAlexandre Jentzer, Aymeric Cantais, Xavier Roblin, et al.
Journal of Crohn'S & Colitis|September 25, 2019
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-ResponseMiles P Sparrow, Konstantinos Papamichael, Mark G Ward, et al.
Gastroenterologie Clinique Et Biologique|January 2, 2008
[Osteosarcoma: a rare cause of primary liver tumor]Jean Marc Phelip, Nathalie Sturm, Xavier Roblin, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Comparison of adiponectin concentration between pancreatic cancer and colorectal cancerJean Marc Phelip, Serban Bageacu, Mathieu Baconnier, et al.
The American Journal of Gastroenterology|June 11, 2014
Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseasesXavier Roblin, M Rinaudo, E Del Tedesco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 18, 2017
Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinomaNicolas Williet, Léa Clavel, Aurélie Bourmaud, et al.
Digestive Diseases and Sciences|September 16, 2020
No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose IntensificationStephane Paul, Nicolas Williet, Stéphane Nancey, et al.
Digestive Diseases and Sciences|July 26, 2006
MacDuffie syndrome and primary sclerosing cholangitis: an exceptional associationXavier Roblin, Jean-Marc Phelip, Marie Noelle Hilleret, et al.
Pageof 26

Showing results (111-120 of 252) with videos related to

Sort By:
Pageof 26
Journal of Cancer Research and Clinical Oncology|March 14, 2021
Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinomaMathilde Barrau, Khawla Maoui, Bertrand Le Roy, et al.
Expert Review of Gastroenterology & Hepatology|October 9, 2024
Therapeutic drug monitoring in inflammatory bowel disease: recent developmentsXavier Roblin, Robert D Little, Nicolas Mathieu, et al.
Viruses|April 26, 2025
Predictive Factors of Cytomegalovirus Colonic Reactivation in Patients with Active Ulcerative ColitisAlexandre Jentzer, Aymeric Cantais, Xavier Roblin, et al.
Journal of Crohn'S & Colitis|September 25, 2019
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-ResponseMiles P Sparrow, Konstantinos Papamichael, Mark G Ward, et al.
Gastroenterologie Clinique Et Biologique|January 2, 2008
[Osteosarcoma: a rare cause of primary liver tumor]Jean Marc Phelip, Nathalie Sturm, Xavier Roblin, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
Comparison of adiponectin concentration between pancreatic cancer and colorectal cancerJean Marc Phelip, Serban Bageacu, Mathieu Baconnier, et al.
The American Journal of Gastroenterology|June 11, 2014
Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseasesXavier Roblin, M Rinaudo, E Del Tedesco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 18, 2017
Tolerance and outcomes of sorafenib in elderly patients treated for advanced hepatocellular carcinomaNicolas Williet, Léa Clavel, Aurélie Bourmaud, et al.
Digestive Diseases and Sciences|September 16, 2020
No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose IntensificationStephane Paul, Nicolas Williet, Stéphane Nancey, et al.
Digestive Diseases and Sciences|July 26, 2006
MacDuffie syndrome and primary sclerosing cholangitis: an exceptional associationXavier Roblin, Jean-Marc Phelip, Marie Noelle Hilleret, et al.
Pageof 26